SCHEMBL14645191

SCHEMBL14645191

C#CCOCCOCCOc1ccc(NC(=O)O)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.44
MEN1 O00255 4/20 0.44
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 1/20 0.42
APP P05067 2/20 0.42
TP53 P04637 2/20 0.42
PPARA Q07869 1/20 0.42
EPHX2 P34913 2/20 0.41
MMP2 P08253 1/20 0.41
MMP9 P14780 1/20 0.41
MMP8 P22894 1/20 0.41
MMP13 P45452 1/20 0.41
MAPT P10636 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP3A4 P08684 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14645383 0.82 PTPN11 (0.44) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL26992265 0.81 EPHX2 (0.41) KMT2AMEN1RAB9AALDH1A1APP
SCHEMBL30693907 0.81 ALDH1A1 (0.49) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL14645321 0.81 EPHX2 (0.46) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL22495331 0.79 PKM (0.62) ALDH1A1TSHRTP53L3MBTL1
SCHEMBL31502389 0.78 PLA2G4B (0.47) ALDH1A1TSHRMMP2MMP9MMP8
SCHEMBL29262374 0.78 SMN1; SMN2 (0.48) NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL31503058 0.77 MAPT (0.57) KMT2AMEN1NPC1RAB9AALDH1A1
SCHEMBL19332007 0.77 HDAC3 (0.47) NPC1RAB9ASMN1; SMN2TP53PPARA
SCHEMBL16561515 0.77 GAA (0.59) RAB9AALDH1A1SMN1; SMN2PPARAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2729178-A1 TYROSINE LIGATION PROCESS Novartis AG (CH) 2014-05-14 EP disclosed
WO-2013009564-A1 TYROSINE LIGATION PROCESS NOVARTIS AG (CH) 2013-01-17 WO disclosed